Aficamten outperforms beta-blockers in treating patients with obstructive hypertrophic cardiomyopathy
Aficamten treatment was associated with significant improvements in exercise capacity and symptoms compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), according to late-breaking research presented in a…